Open Access

About the speakers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
79 presentations
12 followers

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
33 presentations
5 followers

Professor Fabrice Martens

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
2 presentations
0 follower

Professor Erin Michos

The Johns Hopkins University School of Medicine, Baltimore (United States of America)
5 presentations
3 followers

5 more presentations in this session

Introduction

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

The evolving need and challenges to reach LDL-c targets in high-risk patients

Speaker: Professor K. Ray (London, GB)

Thumbnail

Oral LDL-c lowering therapies - the basis of prevention

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Thumbnail

PCSK9i: expanding benefits across the spectrum of cardiovascular disease

Speaker: Professor F. Martens (Amsterdam, NL)

Thumbnail

Novel oral pathways in LDL-c lowering therapy: the new promise of oral CETP inhibitors

Speaker: Professor E. Michos (Baltimore, US)

Thumbnail

Access the full session

The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management

Speakers: Professor K. Ray, Professor J. Kastelein, Professor F. Martens, Professor E. Michos, Professor J. Kastelein...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb